Compound Summary
Compound Information
Tretazicar
Compound Name: | Tretazicar |
Compound CID: | 89105 |
Synonyms: | Tretazicar 21919-05-1 CB 1954 CB1954 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE More... |
Iupac Name: | 5-(aziridin-1-yl)-2,4-dinitrobenzamide |
InChI: | InChI=1S/C9H8N4O5/c10-9(14)5-3-7(11-1-2-11)8(13(17)18)4-6(5)12(15)16/h3-4H,1-2H2,(H2,10,14) |
InChIKey: | WOCXQMCIOTUMJV-UHFFFAOYSA-N |
Canonical Smiles: | C1CN1C2=C(C=C(C(=C2)C(=O)N)[N+](=O)[O-])[N+](=O)[O-] |
Isomeric Smiles: | C1CN1C2=C(C=C(C(=C2)C(=O)N)[N+](=O)[O-])[N+](=O)[O-] |
Molecular Weight: | 252.18 |
Molecular Formula: | C9H8N4O5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Tretazicar
Molecular Weight: | 252.18 |
Molecular Formula: | C9H8N4O5 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 18 |
Complexity: | 385 |
Synonyms
Tretazicar
| Tretazicar | Tretazicar |
|---|---|
Tretazicar |
21919-05-1 |
CB 1954 |
CB1954 |
5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE |
5-Aziridino-2,4-dinitrobenzamide |
5-(1-Aziridinyl)-2,4-dinitrobenzamide |
CB-1954 |
5-Aziridinyl-2,4-dinitrobenzamide |
Benzamide,5-(1-aziridinyl)-2,4-dinitro- |
2,4-Dinitroethyleneiminobenzamide |
2,4-Dinitro-5-ethyleneiminobenzamide |
NSC 115829 |
CHEMBL23330 |
UNII-7865D5D01M |
MFCD00869490 |
7865D5D01M |
NSC-115829 |
CB1 |
5-aziridin-1-yl-2,4-dinitrobenzamide |
SMR000326847 |
Tretazicar INN |
CCRIS 1631 |
BRN 5825582 |
CB1954(Tretazicar) |
CB1954; Tretazicar |
CB 1954, solid |
Lopac-C-2235 |
Benzamide, 5-(1-aziridinyl)-2,4-dinitro- |
Lopac0_000200 |
MLS000859988 |
MLS001066333 |
SCHEMBL366755 |
SCHEMBL15691893 |
DTXSID00176335 |
HMS2233F04 |
HMS3260H21 |
HMS3369C05 |
BCP09250 |
WLN: T3NTJ AR CVZ DNW FNW |
ZINC4475105 |
Tox21_500200 |
BDBM50004681 |
CB 954 |
NSC115829 |
s7829 |
AKOS030239859 |
5-aziridin-1-yl-2,4-dinitrobenzamide |
CCG-204295 |
DB04253 |
LP00200 |
SDCCGSBI-0050188.P002 |
5-aziridin-1-yl-2,4-dinitro-benzamide |
NCGC00015220-01 |
NCGC00015220-02 |
NCGC00015220-03 |
NCGC00015220-04 |
NCGC00015220-05 |
NCGC00093675-01 |
NCGC00093675-02 |
NCGC00260885-01 |
AS-63985 |
HY-13543 |
NCI60_000357 |
CS-0007140 |
EU-0100200 |
C 2235 |
C74095 |
28334-EP2269990A1 |
28334-EP2280001A1 |
28334-EP2281824A1 |
28334-EP2301923A1 |
28334-EP2301930A1 |
28334-EP2308869A1 |
28334-EP2314578A1 |
919A051 |
SR-01000075746 |
J-014359 |
SR-01000075746-1 |
Q27095075 |
CB-954;CB1954;NSC 115829; CB 1954 |
Experimental Data
Tretazicar
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -11 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Tretazicar
Statistics Data
Tretazicar
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -11 | 1 | 1 |
Statistics Data Visualization
Tretazicar
